Group 1 - Kenvue, the maker of Tylenol, is facing backlash due to unsupported claims linking its product to autism, which may lead to further scrutiny of other medications [1] - Robert F. Kennedy Jr. is leveraging his position to push unverified health claims into public policy, impacting access to various medications [1][2] - Kennedy's "Make America Healthy Again" initiative targets multiple drugs, including antidepressants and statins, raising concerns about their safety and necessity [3][4] Group 2 - The initiative aims to assess the risks associated with selective serotonin reuptake inhibitors, which are used by approximately 11% of the population for mental health issues [3] - Statins, prescribed to over 92 million Americans, are also under scrutiny despite evidence supporting their safety and effectiveness in preventing heart disease [4] - Kennedy's organization has published articles questioning the efficacy of cholesterol-related treatments, suggesting they are overprescribed [5] Group 3 - Newer diabetes and obesity treatments, such as GLP-1s, are also being criticized by Kennedy, who has made false claims about their marketing and effectiveness [6][7] - A proposal to have Medicare cover GLP-1 drugs for obesity was rejected, potentially limiting access for 7 million Americans [8] - Kennedy's rhetoric suggests a broader agenda against pharmaceutical companies and their products, raising concerns about future restrictions on various medications [1][8]